Clinical trials recruiting for Inflammatory bowel disease
63
Recruiting trials
29
US states with sites
49
Countries
21%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Texas | 7 |
| California | 5 |
| Massachusetts | 5 |
| North Carolina | 5 |
| New York | 4 |
| Kentucky | 3 |
| Missouri | 3 |
| Pennsylvania | 3 |
| Colorado | 2 |
| Florida | 2 |
| Georgia | 2 |
| Kansas | 2 |
Top cities
Boston, Massachusetts 5New York, New York 4Chapel Hill, North Carolina 3Durham, North Carolina 3Atlanta, Georgia 2Austin, Texas 2Cedar Park, Texas 2Colorado Springs, Colorado 2Houston, Texas 2Kissimmee, Florida 2
Self-screener
Recruiting trials
- A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule
- A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- A Study to Evaluate Biomarkers in Moderate to Severe Ulcerative Colitis (UC) Patients Treated With Different Targeted Therapies
- Acupuncture Reduces Relapse in Patients With Crohn's Disease: a Superiority Trial
- BOOM-IBD2 Pivotal Clinical Trial
- Beta-Hydroxybutyrate Feasibility Treating IBD
- COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)
- Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
- Clinical Value of Intestinal Ultrasound in Predicting Clinical Relapse in Crohn's Disease Patients in Deep Remission: a Multicenter Prospective Observational Study
- Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases
- Colectomy Reconstruction for Ulcerative Colitis, Ileorectal Anastomosis vs Ileal Pouch-Anal Anastomosis in Ulcerative Colitis.
- Colorectal Omics and OfCS Proteoglycans
- Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis
- Control Crohn Safe Trial
- Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease
- Digestive Biobank for Exploring Microbiota-host Interactions
- Early Inflammatory Bowel Disease Progression
- Effect of Acupuncture on Mild to Moderate Active Crohn's Disease
- Effect of Anti-inflammatory Diet in Patients With Inflammatory Bowel Disease
- Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases
- Evolution and Treatments of Chronic Inflammatory Systemic Diseases
- Faesiblity and Safety of Endoscopic sLeeve gastrOplasty in Patients With obEsity and nflammatoRy Bowel Disease
- Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance
- Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population
- Fermented Food-Supplemented Diet in Ulcerative Colitis
- Genome Analysis Across Populations in Inflammatory Bowel Disease
- Gut Microbiome in Inflammatory Bowel Disease
- IBD Strong Peer2Peer for Self-Management of Psychological Distress
- IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASE
- Inflammatory Bowel Disease Cohort in Nantes
- Institutional Registry of Rare Diseases
- Intestinal Ultrasound Guided Management in Inflammatory Bowel Disease
- Investigation of VAP-1 Expression and Tissue Blood Flow by PET-MRI in Patients With Crohn's Disease
- Investigation of the Correlation Between Polyamine Levels and Their Key Enzymatic Activities in Association With Inflammatory Bowel Disease Progression
- Longitudinal Study on Bacterial Production of LPC and LPA in Patients With Inflammatory Bowel Disease
- Metformin as Added on Therapy in Patients With Ulcerative Colitis
- Microbial Restoration in Inflammatory Bowel Diseases
- NAZA - Nottingham/Astra ZenecA Prospective IBD Cohort Study
- Nutrition and Clinical Outcomes in IBD
- Observational Pharmaco-Epidemiology Research & Analysis
- PIBD-SETQuality: the Inception Cohort and Safety Registry
- Pentoxifylline in Patients With Ulcerative Colitis
- Personalized B-fructan Diet in Inflammatory Bowel Disease Patients
- Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility
- Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis.
- Predicting IBD Treatment Outcomes With Gut Microbiome Analysis
- Predictors of Prognosis in IBD Patients
- Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients
- Registry and Biorepository for IBD in Central Texas
- Regulation of Mucosal Healing in Inflammatory Bowel Disease
- Resting Energy Expenditure in Pediatric Patients With Inflammatory Bowel Disease (REE-MICI)
- Robotic Inflammatory Bowel Disease Development, Learning and Efficacy Study
- Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease
- Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)
- Study of an Environmental Risk Factor in Crohn's Disease
- Subcutaneous Infliximab After A Previous Intravenous Dose Optimization
- Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
- Texture and Color Enhancement Imaging (TXI) for Inflammation Assessment in Patients With Inflammatory Bowel Diseases
- The Assessment of Infrared Treatment for Crohn's Disease
- Therapeutic Endpoint in Pediatric IBD Conditions
- VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems
Related conditions
Trials recruiting for Inflammatory bowel disease often also study these conditions. Each links to its own recruiting-trial list.
Crohn's disease 328Ulcerative colitis 288Colitis, Ulcerative 33Colorectal cancer 1359Rheumatoid arthritis 314Psoriasis 233Obesity 1512Lupus 332Indeterminate Colitis 6Depression 1463
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Inflammatory bowel disease trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.